BioSpace News Archive

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today successful completion of a series of preclinical experiments requested by the United States Food and Drug Administration (FDA) in order to begin Phase I/II clinical trials.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that nearly 6,000 people with amyotrophic lateral sclerosis (ALS) in the U.S. have received treatment with RADICAVA® (edaravone) since it became available to patients four years ago.

City of Hope, a world-renowned cancer research and treatment center, announced that acclaimed Pacific Shores Medical Group has joined City of Hope.

Global biotherapeutics leader CSL Behring today announced that the European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Task Force has released an update to its guideline on diagnosis and treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).

Halberd Corporation released a 120-page compilation of medical articles in support of its Vita-Shield-MaxTM Nutraceutical product earlier.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) has granted provisional registration to the COVID-19 Vaccine Moderna in Australia for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 18 years of age and older

Gene expression profiling is the genomic technique which determines the pattern of genes expressed, by being transcribed into messenger RNA (mRNA), under specific conditions or in a particular cell to give a whole picture of cellular function.

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Sonitor, the leading provider and innovator of ultrasound-based Real-Time Location Systems (RTLS) and Indoor Positioning Systems (IPS) will comply with the latest county, state and federal guidance to ensure the safety and health of attendees and staff as it exhibits at HIMSS Global Health Conference & Exhibition August 9-13, 2021 in the Venetian Ballroom of the Sands Expo Convention Center, Las Vegas, in booth #7430.

The kit allow the immobilization of nucleic acid specifically by filter tube while they are freed of contaminants.